Earnings History Data for Mereo BioPharma Group plc (MREO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a biopharmaceutical company. It is focused on development and commercialization of therapeutics for patients with rare diseases. The company's product pipeline includes BPS-804, MPH-966, BCT-197, BGS-649, Navicixizumab and Etigilimab which are in clinical stage. Mereo BioPharma Group PLC is based in London, United Kingdom.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-03-2023	??	MREO	Mereo BioPharma Group plc	120.90	N/A	0.00	0.00	Mereo BioPharma Group GAAP EPS of -£0.06 [3/28/2023 4:41 PM]	0.74	-0.02 (-2.34%)	0.0	0.0 (0.00%)	0.30 - 1.85	1,118,891	780,000	0

31-03-2022	AH	MREO	Mereo BioPharma Group plc	150.28	N/A	0.00	0.00	Mereo BioPharma Group GAAP EPS of -£0.05, revenue of £36.46M [3/31/2022 4:50 PM]	1.09	-0.03 (-2.68%)	1.11	-0.01 (-0.89%)	1.03 - 4.29	460,941	820,000	1,165
Mereo BioPharma Group GAAP EPS of -£0.05, revenue of £36.46M [3/31/2022 4:50 PM] Mereo BioPharma Reports Full Year 2021 Financial Results and Recent Highlights [Mar-31-22 04:01PM]